Phase I, open-label study of pasireotide in patients with BRAF-wild type and NRAS-wild type, unresectable and/or metastatic melanoma

INTRODUCTION: Somatostatin analogues exert antitumour activity via direct and indirect mechanisms. The present study was designed to assess the safety and efficacy of pasireotide in patients with BRAF-wild type (WT) and NRAS-WT metastatic melanoma. PATIENTS AND METHODS: Patients with unresectable an...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:ESMO Open
Main Authors: Dummer, Reinhard, Michielin, Olivier, Nägeli, Mirjam Chantal, M. Goldinger, Simone, Campigotto, Federico, Kriemler-Krahn, Ulrike, Schmid, Herbert, Pedroncelli, Alberto, Micaletto, Sara, Schadendorf, Dirk
Format: Artigo
Sprog:Inglês
Udgivet: BMJ Publishing Group 2018
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6069912/
https://ncbi.nlm.nih.gov/pubmed/30094073
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2018-000388
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker